ASX:CHM – Strategic $6.6M Capital Raise to Accelerate Clinical Trial Development
Chimeric Therapeutics has secured significant funding through a strongly supported placement, demonstrating market confidence in its innovative cell therapy programs. Capital Raising Overview...